Video Latest - ecancer

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

ASCO 2013 highlights

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

Crizotinib superior to chemo for advanced ALK positive NSCLC

Dr Suresh S. Ramalingam - Emory University, Atlanta, USA

6 Jun 2013

Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer

Dr Suresh S. Ramalingam - Emory University, Atlanta, USA

3 Jun 2013

Cetuximab superior to bevacizumab for advanced colorectal cancer

Dr Volke Heinemann - University of Munich Munich, Germany

1 Jun 2013

New targets for squamos cell carcinoma

Dr Martin Reck – Hospital Grosshansdorf, Wohrendamm, Germany

16 May 2013

European Thoracic Oncology Platform

Dr Solange Peters - Lausanne University, Switzerland

16 May 2013

Diagnosis and treatment in rare cases of thymoma

Dr Walter Klepetko - Vienna Medical University, Austria

16 May 2013

Integrating breast cancer genomics and proteomics

Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA

15 May 2013

Next wave of successful drug therapy strategies in HER2-positive breast cancer

Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium

15 May 2013

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

Dr Ivana Sestak - Queen Mary University of London, UK

15 May 2013

How do we design trials that improve outcome?

Dr Lisa Carey - University of North Carolina, Chapel Hill, USA

15 May 2013

Video